Society guideline links: Management of Burkitt lymphoma

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of lymphoma (2020)

●International Lymphoma Radiation Oncology Group (ILROG): Guidelines on the optimal use of imaging in radiation therapy for lymphoma (2019)

●ILROG: Field and dose guidelines for modern radiation therapy for extranodal lymphomas (2015)

●International Society of Paediatric Oncology (SIOP): Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting (2013)

Canada

●Choosing Wisely Canada: Don't request a fine-needle aspirate (FNA) for the evaluation of suspected lymphoma (updated 2020)

●Cancer Care Ontario (CCO): Safety considerations for the implementation of subcutaneous rituximab formulation (2018)

●CCO: Consensus pathology recommendations for complex malignant hematology (2016)

●CCO: PET imaging in lymphoma (2015)

●CCO: Rituximab in lymphoma and chronic lymphocytic leukemia – A clinical practice guideline (2015)

United States